Davis R M Inc Abb Vie Inc. Transaction History

Davis R M Inc

$5.09 Billion
Q3 2024

A detailed history of Davis R M Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Davis R M Inc holds 19,293 shares of ABBV stock, worth $3.39 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

19,293

Previous 19,414 0.62%

Holding current value

$3.39 Million

Previous $3.33 Million 14.42%

% of portfolio

0.07%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $19,824 - $24,118	-121 Reduced 0.62%	19,293 $3.81 Million
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $8,203 - $9,580	53 Added 0.27%	19,414 $3.33 Million
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $94,933 - $108,167	-594 Reduced 2.98%	19,361 $3.53 Million
Q4 2023 Feb 09, 2024	SELL	$137.6 - $154.97 $218,508 - $246,092	-1,588 Reduced 7.37%	19,955 $3.09 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $202,522 - $234,449	-1,516 Reduced 6.57%	21,543 $3.21 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $111,308 - $138,516	840 Added 3.78%	23,059 $3.11 Million
Q1 2023 May 01, 2023	SELL	$144.61 - $166.54 $178,882 - $206,009	-1,237 Reduced 5.27%	22,219 $3.54 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $20,746 - $24,880	-150 Reduced 0.64%	23,456 $3.79 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $209,770 - $240,592	-1,563 Reduced 6.21%	23,606 $3.17 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $75,140 - $95,528	546 Added 2.22%	25,169 $3.86 Million
Q1 2022 May 05, 2022	BUY	$131.98 - $163.75 $487,138 - $604,401	3,691 Added 17.63%	24,623 $3.99 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $6,445 - $8,155	-60 Reduced 0.29%	20,932 $2.83 Million
Q3 2021 Nov 08, 2021	SELL	$106.4 - $120.78 $35,005 - $39,736	-329 Reduced 1.54%	20,992 $2.26 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $70,385 - $78,413	669 Added 3.24%	21,321 $2.4 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $45,523 - $50,115	-445 Reduced 2.11%	20,652 $2.24 Million
Q4 2020 Jan 27, 2021	BUY	$80.49 - $108.67 $222,232 - $300,037	2,761 Added 15.06%	21,097 $2.26 Million
Q3 2020 Dec 01, 2020	BUY	$85.91 - $100.83 $83,934 - $98,510	977 Added 5.63%	18,336 $1.61 Million
Q2 2020 Jul 20, 2020	SELL	$73.37 - $98.18 $8,217 - $10,996	-112 Reduced 0.64%	17,359 $1.7 Million
Q1 2020 Apr 24, 2020	SELL	$64.5 - $97.79 $105,973 - $160,668	-1,643 Reduced 8.6%	17,471 $1.33 Million
Q4 2019 Jan 23, 2020	SELL	$72.13 - $90.25 $91,460 - $114,437	-1,268 Reduced 6.22%	19,114 $1.69 Million
Q3 2019 Oct 24, 2019	SELL	$62.98 - $75.72 $93,777 - $112,747	-1,489 Reduced 6.81%	20,382 $1.54 Million
Q2 2019 Jul 31, 2019	SELL	$65.7 - $83.98 $141,320 - $180,640	-2,151 Reduced 8.95%	21,871 $1.59 Million
Q1 2019 Apr 29, 2019	SELL	$77.14 - $90.79 $215,992 - $254,212	-2,800 Reduced 10.44%	24,022 $1.94 Million
Q4 2018 Jan 18, 2019	SELL	$77.85 - $96.01 $89,527 - $110,411	-1,150 Reduced 4.11%	26,822 $2.47 Million
Q3 2018 Oct 17, 2018	BUY	$88.91 - $98.84 $13,425 - $14,924	151 Added 0.54%	27,972 $2.65 Million
Q2 2018 Jul 19, 2018	SELL	$89.78 - $106.23 $173,634 - $205,448	-1,934 Reduced 6.5%	27,821 $2.58 Million
Q1 2018 Apr 19, 2018	SELL	$92.01 - $123.21 $70,019 - $93,762	-761 Reduced 2.49%	29,755 $2.82 Million
Q4 2017 Jan 16, 2018	SELL	$89.56 - $98.21 $40,302 - $44,194	-450 Reduced 1.45%	30,516 $2.95 Million
Q3 2017 Oct 24, 2017	BUY	$69.85 - $89.22 $2.16 Million - $2.76 Million	30,966	30,966 $2.75 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

News

Stay updated on Davis R M Inc with notifications on news.

Account